BioMerieux, a pioneering Microbiology diagnostic company, is thrilled to announce the launch of our latest innovation in antimicrobial susceptibility testing (AST): the Gram-Negative AST Card for Colistin. Designed to enhanced accuracy and efficiency, this cutting-edge card is set to revolutionize Colistin susceptibility testing.
Multidrug-resistant strains of Pseudomonas aeruginosa and Acinebacter baumannii, along with carbapenemase-producing Enterobacteriaceae, are incresingly common. As a consequence, Colistin is being used more frequently, and the emergence of Colistin-resistant strains in these bacteria is a major concern for clinical and public health reasons. Our newly developed AST card for colistin empowers healthcare professionals with a comprehensive and reliable solution, allowing them to make informed therapeutic decisions swiftly and confidently.
Key Features and Advantages:
1. New and improved version of Colistin (cs02n) antibiotic
2. Effective against Acinebacter spp., Enterobacteriaceae and Pseudomonas aeruginosa*
3. Validated for use with the latest CLSI breakpoints for Colistin
4. Accurate performance
5. Essential agreement (EA) and category agreement (CA) are 92.3% and 94.2%, respectively, compared to the reference method, Broth Microdilution
6. Polymyxin B can be deduced from Colistin
7. Yields results in as little as 5 hours
We are confident that our Gram-Negative AST Card for Colistin will significantly impact patient care and antimicrobial resistance management. The enhanced accuracy and efficiency it brings will enable healthcare professionals to make informed treatment decisions promptly, improving patient outcomes and overall antimicrobial stewardship.
BioMerieux remains committed to advancing medical diagnostics, striving to empower healthcare providers with innovative tools to address the evolving challenges of infectious diseases. Together, let us make a difference in the fight against antimicrobial resistance!
Note: Gram-Negative AST Card for Colistin is for laboratory and professional use only.
Disclaimer: Please consult the product labeling, instructions for use, and relevant guidelines for the most accurate and up-to-date information regarding the use of the Gram-Negative AST Card for Colistin in your region.